Figure 3From: Prognosis of screen-detected breast cancers: results of a population based study 5-year survival of pT1a+b (3a) and pT1c (3b). 5-year OS values of pT1a+b (a) and pT1c (b) breast cancers between MSP participants and non-participants were equal to 98% and 96% (Log Rank = 0.76) respectively (a) and 93% and 89% (Log Rank = 1.57) respectively (b). [ = MSP participants; = MSP non-participants]Back to article page